Prosecution Insights
Last updated: October 01, 2026

Examiner: JACKSON III, WALTER

Tech Center 3700 • Art Units: 1631 1633 1638 1647 1663 1674 1675 3715

This examiner grants 100% of resolved cases

Analysis

Walter Jackson III is an examiner in Tech Center 3700 and Art Unit 1631. The profile contains extremely thin data, with only 1 resolved case recorded. This single case resulted in an allowance, yielding an allowance rate of 100.0 percent. While this 100.0 percent figure is positive, it is based on a very limited sample size and may not represent long-term trends.

The interview lift is 0.0 percent, reflecting no change in outcome based on the interview for the single resolved matter. The median days to allowance is 1006. Because this 1006 day figure is based on only 1 case, it should be viewed as a single data point rather than a broad average for the examiner's docket. Practitioners should consider these statistics as a snapshot of a very early or limited docket.

Given the 1 resolved case and the 1006 day timeline, it is difficult to draw definitive conclusions about the examiner's overall style. Applicants should monitor future case resolutions to see if the 100.0 percent allowance rate and other metrics stabilize as more applications are processed through this art unit.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

100.0%
Allow Rate
+30.0% vs TC avg
27
Total Applications
+0.0%
Interview Lift
1006
Avg Prosecution Days
Based on 1 resolved cases, 2023–2026

Rejection Statute Breakdown

3.9%
§101 Eligibility
13.9%
§102 Novelty
63.9%
§103 Obviousness
13.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18635082 METHOD OF GENERATING iPS CELL AND iPS CELL GENERATION SYSTEM Non-Final OA Canon Kabushiki Kaisha
18811675 GENERATION OF HUMAN SPINAL CORD NEURAL STEM CELLS Non-Final OA THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
18410249 ENHANCERS DRIVING EXPRESSION IN MOTOR NEURONS Non-Final OA President and Fellows of Harvard College
18847998 METHOD FOR THE PRODUCTION OF BIOLOGICAL TISSUE Non-Final OA BIOTRONIK AG
18682573 ENDOMETRIAL MODEL, METHOD FOR PREPARING ENDOMETRIAL MODEL, AND ENDOMETRIAL IMPLANTATION MODEL Final Rejection TOHOKU UNIVERSITY
18423327 3D ARTIFICIAL SKIN MODEL AND METHOD FOR PRODUCING THE SAME Non-Final OA Korea Advanced Institute of Science and Technology
18417028 METHOD FOR PREPARING TASTE BUD ORGANOIDS USING ANTERIOR TONGUE EPITHELIAL CELLS Final Rejection Korea University Research and Business Foundation
18485192 METHODS AND DEVICES FOR GENERATING EMBRYOS IN VITRO FROM EMBRYONIC STEM CELLS Final Rejection Cambridge Enterprise Limited
18718343 METHOD FOR OBTAINING A NEUROMUSCULAR ORGANOID AND USE THEREOF Non-Final OA Universiteit Antwerpen
18569178 CANCER THERAPIES COMPRISING PEPTIDE LOADED CXCR3- AND CCR5-INDUCING DENDRITIC CELLS AND CHEMOKINE MODULATORY AGENTS Non-Final OA H. Lee Moffitt Cancer Center and Research Institute, Inc.
18607056 Treatment of Dry Age-Related Macular Degeneration Non-Final OA Genzyme Corporation

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month